Jacobs Jan A, Stobberingh Ellen E, Cornelissen Elisa I M, Drent Marjolein
Department of Medical Microbiology, University Hospital of Maastricht, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.
J Clin Microbiol. 2005 Aug;43(8):4037-40. doi: 10.1128/JCM.43.8.4037-4040.2005.
We conducted a retrospective study to evaluate an immunochromatographic membrane test (ICT), applied to bronchoalveolar lavage (BAL) fluid samples obtained in patients with suspected pneumonia, for the detection of Streptococcus pneumoniae antigen. The NOW Streptococcus pneumoniae test was assessed on 96 BAL fluid samples. Sensitivity was tested in 20 samples obtained from patients diagnosed as having pneumococcal pneumonia (growth of S. pneumoniae in blood cultures and/or in BAL fluid samples of > or =10(4) CFU/ml). Specificity was tested in BAL fluid samples of nonpneumococcal etiology (n = 41) and in samples with no respiratory pathogen and a total bacterial count of <10(4) CFU/ml (n = 35). Using the ICT, pneumococcal antigen was detected in 29 (30.2%) BAL fluid samples, with a sensitivity of 95.0% (95% confidence interval [CI], 90.6% to 99.4%) and a specificity of 86.8% (95% CI, 80.1% to 93.8%). The ICT was easy to perform and revealed unequivocal and reproducible results. No interference was observed with high cell counts, red blood cells, or elevated protein levels. Four out of 10 false-positive readings occurred in samples with S. pneumoniae counts below the 10(4) CFU/ml threshold limit of pneumonia. In BAL fluid samples obtained after pneumococcal bacteremia, positive test results were found for up to 35 days after bacteremia. The ICT test applied to BAL fluid specimens is reproducible and accurate in the diagnosis of pneumococcal antigen. Further studies are required to establish the impact of the ICT on patient care.
我们进行了一项回顾性研究,以评估免疫层析膜试验(ICT)在检测疑似肺炎患者支气管肺泡灌洗(BAL)液样本中肺炎链球菌抗原的应用情况。对96份BAL液样本进行了NOW肺炎链球菌检测。在从被诊断患有肺炎球菌肺炎的患者中获取的20份样本中测试了敏感性(血培养中肺炎链球菌生长和/或BAL液样本中菌落形成单位[CFU]/ml≥10⁴)。在非肺炎球菌病因的BAL液样本(n = 41)以及无呼吸道病原体且总细菌计数<10⁴CFU/ml的样本(n = 35)中测试了特异性。使用ICT,在29份(30.2%)BAL液样本中检测到肺炎球菌抗原,敏感性为95.0%(95%置信区间[CI],90.6%至99.4%),特异性为86.8%(95%CI,80.1%至93.8%)。ICT操作简便,结果明确且可重复。未观察到高细胞计数、红细胞或蛋白质水平升高产生干扰。10例假阳性读数中有4例出现在肺炎链球菌计数低于肺炎10⁴CFU/ml阈值的样本中。在肺炎球菌菌血症后获取的BAL液样本中,菌血症后长达35天检测到阳性试验结果。应用于BAL液标本的ICT试验在肺炎球菌抗原诊断中具有可重复性和准确性。需要进一步研究以确定ICT对患者护理的影响。